Cart
sales@molnova.com
JNJ-65355394
CAS No. 2230598-99-7
JNJ-65355394( —— )
Catalog No. M35965 CAS No. 2230598-99-7
JNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | Get Quote |
|
| 5MG | 265 | Get Quote |
|
| 10MG | 377 | Get Quote |
|
| 25MG | 591 | Get Quote |
|
| 50MG | 789 | Get Quote |
|
| 100MG | 1035 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJNJ-65355394
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-65355394 is an effective O-GlcNAc hydrolase (OGA) inhibitor and an OGA chemical probe.
-
DescriptionJNJ-65355394 (Compound 28) is an O-GlcNAc hydrolase (OGA) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230598-99-7
-
Formula Weight358.5
-
Molecular FormulaC19H26N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1SC(NC(C)=O)=NC1)N2C[C@@H](CC=3C=C(C)N=C(C)C3)CCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. José Manuel BARTOLOMé-NEBREDA, et al. Monocyclic oga inhibitor compounds. Patent WO2018109202A1.
molnova catalog
related products
-
Olokizumab
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .
-
Sendai Virus Nucleop...
Sendai Virus Nucleoprotein (SV9), 324 - 332
-
Glycoprotein Hormone...
Glycoprotein Hormone a (32-46) amide
